“…Also, in patients in the CABG cohort of the SYNTAX trial [51], the 5-year incidence of major adverse cardiac and cerebrovascular events did not significantly differ according to the extent of revascularization, whereas this was significantly lower after CR (33%) compared with IR (43% after IR, P ¼ 0.010) in the PCI cohort. This discordance may be explained by hypothesizing that bypass conduits, unlike stents, offer some sort of protection against the progression of preexisting lesions to plaque rupture, or the evolution of new and undiagnosed disease toward final events [52], thus rendering the type, length, degree, and complexity of stenoses less relevant in CABG compared with PCI. In addition, IR in PCI occurs more frequently in patients with highly complex CAD, whereas IR in CABG encompasses either small or diffusely diseased vessels, often with limited downstream ischemic territories.…”